Investor Presentaiton
Reagent &
Services
Instrument
Medical Diagnosis - Core Product
Biochemical
Immunodiagnostic
F-C800
F-C800p
77 Routine
Biochemical
Reagents
XPT
5MyCare (Spiritual)
F-i1000
Molecule +
Respiratory
Microbiology &
Tuberculosis
POCT
Chronic Diseases
POCT
Acute Infections
Early Tumor
Screening
SLAN
Amplifier
Rapid
Fluorescence
528
318
Molecule
POCT
GU-2
MLA
F-i3000
TB ES-15
COVID-19
Extractor
GULP
Rapid
Antigen Test
Tumor Markers 15, Thyroid
Function8, Gastric
Function3, Infection3,
Carbohydrate Metabolism2,
Sexhormone8
12 Routine PCR
COVID-19 RT-
PCR Detection Kit
Universal
Extraction Reagent
Monkeypox PCR
Detection Kit
NG-Test
Blood Glucose
Disk Susceptibility Test
for Fungal/Bacteria
Uric Acid
(Ag)
COVID-19
Rapid
Antigen Test
G-TEST
Tuberculosis I-SPOT
Blood Lipid
•
•
•
35
Medical Diagnosis 1H22 Major Progress
In-House Development Collaboration
Services
Promoting the integration of medical diagnosis segment to continuously improve the R&D and manufacturing capabilities of diagnostic instruments
F-C800p Automatic Biochemical Analyzer launched in June 2022, together with the F-i3000 Automated Chemiluminescence Immunoassay Analyzer,
formed Fosun Diagnostics biochemical immunoassay pipeline to meet the clinical diagnostic testing needs
Self-developed COVID-19 Rapid Antigen Test was approved by NMPA in April 2022. It has received EU CE certification and FDA EUA, been
included in the EU Common list of COVID-19 antigen tests and completed BfArM registration in Germany
Self-developed Monkeypox PCR Detection Kit received EU CE certification in May 2022View entire presentation